Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Quirion

Showing results (371-380 of 395) with videos related to

Pageof 40
Sort By:
Brain Research|December 3, 1993
Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive proteinJ A Wood, P L Wood, R Ryan, et al.
Histology and Histopathology|September 18, 2004
Coexistence of reactive plasticity and neurodegeneration in Alzheimer diseased brainsJ Guevara, H Dilhuydy, B Espinosa, et al.
Life Sciences|December 16, 1985
Platelet 3H-imipramine binding distinguishes depression from Alzheimer dementiaB E Suranyi-Cadotte, S Gauthier, F Lafaille, et al.
The European Journal of Neuroscience|September 1, 1995
In vivo modulation of sigma receptor sites by calcitonin gene-related peptide in the mouse and rat hippocampal formation: radioligand binding and electrophysiological studiesP Bouchard, F Monnet, R Bergeron, et al.
Journal of Psychiatric Research|January 1, 1987
Platelet imipramine binding in patients with panic disorder and major familial depressionJ C Pecknold, H Chang, D Fleury, et al.
European Journal of Pharmacology|July 6, 1993
Evaluation of truncated neuropeptide Y analogues with modifications of the tyrosine residue in position 1 on Y1, Y2 and Y3 receptor sub-typesY Dumont, H Satoh, A Cadieux, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 1, 1995
Facilitation of acetylcholine release and cognitive performance by an M(2)-muscarinic receptor antagonist in aged memory-impairedR Quirion, A Wilson, W Rowe, et al.
British Journal of Pharmacology|April 28, 2001
Agonist and antagonist activities on human NPFF(2) receptors of the NPY ligands GR231118 and BIBP3226C Mollereau, C Gouardères, Y Dumont, et al.
British Journal of Pharmacology|March 22, 2000
BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonistY Dumont, A Cadieux, H Doods, et al.
Endocrinology|August 28, 1999
Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtypeP D Raposinho, P Broqua, D D Pierroz, et al.
Pageof 40

Showing results (371-380 of 395) with videos related to

Sort By:
Pageof 40
Brain Research|December 3, 1993
Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive proteinJ A Wood, P L Wood, R Ryan, et al.
Histology and Histopathology|September 18, 2004
Coexistence of reactive plasticity and neurodegeneration in Alzheimer diseased brainsJ Guevara, H Dilhuydy, B Espinosa, et al.
Life Sciences|December 16, 1985
Platelet 3H-imipramine binding distinguishes depression from Alzheimer dementiaB E Suranyi-Cadotte, S Gauthier, F Lafaille, et al.
The European Journal of Neuroscience|September 1, 1995
In vivo modulation of sigma receptor sites by calcitonin gene-related peptide in the mouse and rat hippocampal formation: radioligand binding and electrophysiological studiesP Bouchard, F Monnet, R Bergeron, et al.
Journal of Psychiatric Research|January 1, 1987
Platelet imipramine binding in patients with panic disorder and major familial depressionJ C Pecknold, H Chang, D Fleury, et al.
European Journal of Pharmacology|July 6, 1993
Evaluation of truncated neuropeptide Y analogues with modifications of the tyrosine residue in position 1 on Y1, Y2 and Y3 receptor sub-typesY Dumont, H Satoh, A Cadieux, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 1, 1995
Facilitation of acetylcholine release and cognitive performance by an M(2)-muscarinic receptor antagonist in aged memory-impairedR Quirion, A Wilson, W Rowe, et al.
British Journal of Pharmacology|April 28, 2001
Agonist and antagonist activities on human NPFF(2) receptors of the NPY ligands GR231118 and BIBP3226C Mollereau, C Gouardères, Y Dumont, et al.
British Journal of Pharmacology|March 22, 2000
BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonistY Dumont, A Cadieux, H Doods, et al.
Endocrinology|August 28, 1999
Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtypeP D Raposinho, P Broqua, D D Pierroz, et al.
Pageof 40